Practicing aggressive innovation.

Bringing high-value therapies to the patients who need them requires a keen eye for potential and a dedication to accelerating the development of late-stage assets. We have both.
We are always interested in collaborating with development, manufacturing, and commercialization partners to bring innovative products to patients living with rare diseases.

Keeping the flow going.

Alkindi Sprinkle®
Status: Commercial
Carglumic Acid Tablets
Status: Commercial
Dehydrated Alcohol Injection
Status: Filed
ZENEO Hydrocortisone Autoinjector
Status: Under Development

Interested in a partnership?

Let’s start the conversation.